Silvestri, M.; Reduzzi, C.; Feliciello, G.; Vismara, M.; Schamberger, T.; Köstler, C.; Motta, R.; Calza, S.; Ferraris, C.; Vingiani, A.;
et al. Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers 2021, 13, 1409.
https://doi.org/10.3390/cancers13061409
AMA Style
Silvestri M, Reduzzi C, Feliciello G, Vismara M, Schamberger T, Köstler C, Motta R, Calza S, Ferraris C, Vingiani A,
et al. Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers. 2021; 13(6):1409.
https://doi.org/10.3390/cancers13061409
Chicago/Turabian Style
Silvestri, Marco, Carolina Reduzzi, Giancarlo Feliciello, Marta Vismara, Thomas Schamberger, Cäcilia Köstler, Rosita Motta, Stefano Calza, Cristina Ferraris, Andrea Vingiani,
and et al. 2021. "Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients" Cancers 13, no. 6: 1409.
https://doi.org/10.3390/cancers13061409
APA Style
Silvestri, M., Reduzzi, C., Feliciello, G., Vismara, M., Schamberger, T., Köstler, C., Motta, R., Calza, S., Ferraris, C., Vingiani, A., Pruneri, G., Daidone, M. G., Klein, C. A., Polzer, B., & Cappelletti, V.
(2021). Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers, 13(6), 1409.
https://doi.org/10.3390/cancers13061409